102 related articles for article (PubMed ID: 24602757)
1. Not only type 2 diabetes but also prediabetes is associated with portal inflammation and fibrosis in patients with non-alcoholic fatty liver disease.
Yilmaz Y; Senates E; Yesil A; Ergelen R; Colak Y
J Diabetes Complications; 2014; 28(3):328-31. PubMed ID: 24602757
[TBL] [Abstract][Full Text] [Related]
2. Indices of hepatic steatosis and fibrosis in prediabetes and association with diabetes development in the vitamin D and type 2 diabetes study.
Corbin KD; Pittas AG; Desouza C; Grdinovac KK; Herzig KH; Kashyap SR; Kim SH; Nelson J; Rasouli N; Vickery EM; Knowler WC; Pratley RE
J Diabetes Complications; 2023 Jun; 37(6):108475. PubMed ID: 37104979
[TBL] [Abstract][Full Text] [Related]
3. The roles of type 2 diabetes and obesity in disease activity and progression of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.
Shinde S; Nelson DR; Mitroi J; Heaton PC; Hincapie AL; Brouwers B
Curr Med Res Opin; 2024 Jan; 40(1):59-68. PubMed ID: 37933187
[TBL] [Abstract][Full Text] [Related]
4. Prediction of clinical events by liver stiffness and chronic kidney disease by NAFLD in patients with type-2 diabetes.
Rivera-Esteban J; Pons M; Planas A; Manzano-Nuñez R; Hernández C; Simó-Servat O; Bañeras J; Soler MJ; Seron D; Boixadera A; Augustin S; Simó R; Ferreira-González I; Genescà J; Pericàs JM;
Gastroenterol Hepatol; 2023 Nov; 46(9):682-691. PubMed ID: 36435379
[TBL] [Abstract][Full Text] [Related]
5. Incidence of Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease.
Newton KP; Wilson LA; Crimmins NA; Fishbein MH; Molleston JP; Xanthakos SA; Behling C; Schwimmer JB;
Clin Gastroenterol Hepatol; 2023 May; 21(5):1261-1270. PubMed ID: 35709934
[TBL] [Abstract][Full Text] [Related]
6. Parental History of Type 2 Diabetes Mellitus and PNPLA3 Polymorphism Increase the Risk of Severe Stages of Nonalcoholic Fatty Liver Disease.
Wajsbrot NB; Leite NC; Franca PHC; Cardoso CRL; Salles GF; Villela-Nogueira CA
Dig Dis Sci; 2024 Feb; 69(2):634-642. PubMed ID: 38112841
[TBL] [Abstract][Full Text] [Related]
7. Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease.
Pelusi S; Petta S; Rosso C; Borroni V; Fracanzani AL; Dongiovanni P; Craxi A; Bugianesi E; Fargion S; Valenti L
PLoS One; 2016; 11(9):e0163069. PubMed ID: 27649410
[TBL] [Abstract][Full Text] [Related]
8. Association between weight change and risk of liver fibrosis in adults with type 2 diabetes.
Ke P; Xu M; Feng J; Tian Q; He Y; Lu K; Lu Z
J Glob Health; 2023 Oct; 13():04138. PubMed ID: 37856776
[TBL] [Abstract][Full Text] [Related]
9. Combining diabetes, sex, and menopause as meaningful clinical features associated with NASH and liver fibrosis in individuals with class II and III obesity: A retrospective cohort study.
Raverdy V; Chatelain E; Lasailly G; Caiazzo R; Vandel J; Verkindt H; Marciniak C; Legendre B; Bauvin P; Oukhouya-Daoud N; Baud G; Chetboun M; Vantyghem MC; Gnemmi V; Leteurtre E; Staels B; Lefebvre P; Mathurin P; Marot G; Pattou F
Obesity (Silver Spring); 2023 Dec; 31(12):3066-3076. PubMed ID: 37987186
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of NAFLD - Focus on diabetes.
Younossi ZM; Henry L
Diabetes Res Clin Pract; 2024 Apr; 210():111648. PubMed ID: 38569945
[TBL] [Abstract][Full Text] [Related]
11. Association of thyroid function with non-alcoholic fatty liver disease in recent-onset diabetes.
Saatmann N; Schön M; Zaharia OP; Huttasch M; Strassburger K; Trenkamp S; Kupriyanova Y; Schrauwen-Hinderling V; Kahl S; Burkart V; Wagner R; Roden M;
Liver Int; 2024 Jan; 44(1):27-38. PubMed ID: 37697960
[TBL] [Abstract][Full Text] [Related]
12. Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: A landmark analysis.
Zhang X; Yip TC; Tse YK; Hui VW; Li G; Lin H; Liang LY; Lai JC; Chan HL; Chan SL; Kong AP; Wong GL; Wong VW
Hepatology; 2023 Dec; 78(6):1816-1827. PubMed ID: 37119179
[TBL] [Abstract][Full Text] [Related]
13. Identification of High-Risk Patients With Nonalcoholic Fatty Liver Disease in Endocrinology Clinics.
Younossi ZM; Henry L; Isaacs S; Cusi K
Endocr Pract; 2023 Nov; 29(11):912-918. PubMed ID: 37406857
[TBL] [Abstract][Full Text] [Related]
14. Association between klotho and non-alcoholic fatty liver disease and liver fibrosis based on the NHANES 2007-2016.
Chi Z; Teng Y; Liu Y; Gao L; Yang J; Zhang Z
Ann Hepatol; 2023; 28(5):101125. PubMed ID: 37286168
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the coding accuracy of type 2 diabetes mellitus among patients with non-alcoholic fatty liver disease.
Lee S; Shaheen AA; Campbell DJT; Naugler C; Jiang J; Walker RL; Quan H; Lee J
BMC Health Serv Res; 2024 Feb; 24(1):218. PubMed ID: 38365631
[TBL] [Abstract][Full Text] [Related]
16. NAFLD and type 2 diabetes: A practical guide for the joint management.
Genua I; Iruzubieta P; Rodríguez-Duque JC; Pérez A; Crespo J
Gastroenterol Hepatol; 2023 Dec; 46(10):815-825. PubMed ID: 36584750
[TBL] [Abstract][Full Text] [Related]
17. Diabesity phenotype in relation to the incidence and resolution of nonalcoholic fatty liver disease: A prospective cohort study.
Kong L; Ye C; Wang Y; Dou C; Zheng J; Wang S; Lin H; Zhao Z; Li M; Xu Y; Chen Y; Lu J; Xu M; Wang W; Ning G; Bi Y; Wang T
J Diabetes; 2024 Jan; 16(1):e13459. PubMed ID: 37584361
[TBL] [Abstract][Full Text] [Related]
18. Changes in Fatty Liver Disease and Incident Diabetes Mellitus in Young Korean Adults.
Park KY; Hwang HS; Han K; Park HK
Am J Prev Med; 2024 Apr; 66(4):717-724. PubMed ID: 38008134
[TBL] [Abstract][Full Text] [Related]
19. Non-alcoholic fatty liver disease and periodontal disease: A systematic review and meta-analysis of cross-sectional studies.
Aguiar ILS; Santos-Lins LS; Brasil-Oliveira R; Cotrim HP; Lins-Kusterer L
Arab J Gastroenterol; 2023 Nov; 24(4):198-203. PubMed ID: 37993376
[TBL] [Abstract][Full Text] [Related]
20. Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD.
Balogun O; Wang JY; Shaikh ES; Liu K; Stoyanova S; Memel ZN; Schultz H; Mun L; Bertman J; Rogen CA; Ibrahim MK; Berschback M; Uche-Anya E; Wilechansky R; Simon TG; Corey KE
Hepatol Commun; 2023 Nov; 7(11):. PubMed ID: 37889558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
